SI2488157T1 - Izboljšane formulacije - Google Patents

Izboljšane formulacije

Info

Publication number
SI2488157T1
SI2488157T1 SI201032050T SI201032050T SI2488157T1 SI 2488157 T1 SI2488157 T1 SI 2488157T1 SI 201032050 T SI201032050 T SI 201032050T SI 201032050 T SI201032050 T SI 201032050T SI 2488157 T1 SI2488157 T1 SI 2488157T1
Authority
SI
Slovenia
Prior art keywords
improved formulations
formulations
improved
Prior art date
Application number
SI201032050T
Other languages
English (en)
Slovenian (sl)
Inventor
Rudi Mueller-Walz
Lise-Marie Fueg
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41462451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2488157(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of SI2488157T1 publication Critical patent/SI2488157T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201032050T 2009-10-16 2010-10-15 Izboljšane formulacije SI2488157T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0918150.4A GB0918150D0 (en) 2009-10-16 2009-10-16 Improved formulations
EP10768760.0A EP2488157B1 (en) 2009-10-16 2010-10-15 Improved formulations
PCT/EP2010/065569 WO2011045429A1 (en) 2009-10-16 2010-10-15 Improved formulations

Publications (1)

Publication Number Publication Date
SI2488157T1 true SI2488157T1 (sl) 2021-02-26

Family

ID=41462451

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201032050T SI2488157T1 (sl) 2009-10-16 2010-10-15 Izboljšane formulacije

Country Status (25)

Country Link
US (2) US20120263766A1 (enExample)
EP (2) EP2488157B1 (enExample)
JP (2) JP5818801B2 (enExample)
CN (1) CN102573791B (enExample)
AU (1) AU2010305695B2 (enExample)
BR (1) BR112012008969B1 (enExample)
CA (1) CA2776845C (enExample)
CL (1) CL2012000948A1 (enExample)
CY (1) CY1123918T1 (enExample)
DK (1) DK2488157T3 (enExample)
ES (1) ES2859629T3 (enExample)
GB (1) GB0918150D0 (enExample)
HR (1) HRP20210379T1 (enExample)
HU (1) HUE054030T2 (enExample)
IL (2) IL219162A0 (enExample)
LT (1) LT2488157T (enExample)
MX (1) MX372991B (enExample)
NZ (1) NZ599900A (enExample)
PL (1) PL2488157T3 (enExample)
PT (1) PT2488157T (enExample)
RS (1) RS61430B1 (enExample)
SI (1) SI2488157T1 (enExample)
SM (1) SMT202100150T1 (enExample)
WO (1) WO2011045429A1 (enExample)
ZA (1) ZA201202595B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528640A (en) * 2001-03-30 2004-06-25 Jagotec Ag Medical aerosol formulations
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
JP6335798B2 (ja) * 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
JP2015512929A (ja) * 2012-04-11 2015-04-30 シプラ・リミテッド 医薬組成物
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
CN105963282B (zh) * 2016-05-04 2019-04-19 四川普锐特医药科技有限责任公司 一种医用定量吸入气雾剂
WO2018059390A1 (zh) * 2016-09-29 2018-04-05 广东东阳光药业有限公司 药物组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
AU718263B2 (en) 1995-04-14 2000-04-13 Smithkline Beecham Corporation Metered dose inhaler for salmeterol
AU710382B2 (en) 1995-04-14 1999-09-16 Glaxo Wellcome Inc. Metered dose inhaler for albuterol
JPH101442A (ja) * 1996-06-12 1998-01-06 Taisho Pharmaceut Co Ltd 鼻炎用点鼻薬
CZ295460B6 (cs) * 1997-03-20 2005-08-17 Schering Corporation Způsob výroby aglomerátů a jednotková dávka farmakologicky aktivní látky je obsahující
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
HRP20021025B1 (hr) * 2000-05-22 2013-11-22 Chiesi Farmaceutici S.P.A. Formulacije stabilnih farmaceutskih otopina za inhalatore s odmjerenom dozom pod tlakom
US20030207057A1 (en) 2000-09-18 2003-11-06 Britto Ignatius Loy Metered dose inhaler can coated two or more times with fluorocarbon polymers
ATE320242T1 (de) * 2000-10-09 2006-04-15 3M Innovative Properties Co Medizinische aerosolzusammensetzung
NZ528640A (en) * 2001-03-30 2004-06-25 Jagotec Ag Medical aerosol formulations
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB0201400D0 (en) * 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
WO2004019985A1 (en) * 2002-08-29 2004-03-11 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0327727D0 (en) * 2003-11-28 2003-12-31 Quadrant Drug Delivery Ltd Viral microparticles
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations

Also Published As

Publication number Publication date
WO2011045429A1 (en) 2011-04-21
CN102573791A (zh) 2012-07-11
DK2488157T3 (da) 2021-01-25
ES2859629T3 (es) 2021-10-04
EP2488157B1 (en) 2020-12-30
NZ599900A (en) 2014-11-28
HRP20210379T1 (hr) 2021-04-16
BR112012008969A2 (pt) 2020-06-23
JP2016040286A (ja) 2016-03-24
BR112012008969B1 (pt) 2021-07-06
ZA201202595B (en) 2023-07-26
SMT202100150T1 (it) 2021-05-07
US20170281529A1 (en) 2017-10-05
IL269369A (en) 2019-11-28
CY1123918T1 (el) 2022-05-27
JP5818801B2 (ja) 2015-11-18
AU2010305695A1 (en) 2012-05-03
PL2488157T3 (pl) 2021-06-28
CN102573791B (zh) 2017-09-22
HUE054030T2 (hu) 2021-08-30
EP3811928A1 (en) 2021-04-28
RS61430B1 (sr) 2021-03-31
PT2488157T (pt) 2021-02-05
MX372991B (es) 2020-06-18
CA2776845A1 (en) 2011-04-21
MX2012004338A (es) 2012-08-01
GB0918150D0 (en) 2009-12-02
CA2776845C (en) 2018-04-24
LT2488157T (lt) 2021-02-10
JP2013507429A (ja) 2013-03-04
AU2010305695B2 (en) 2014-07-10
IL219162A0 (en) 2012-06-28
US20180296468A2 (en) 2018-10-18
CL2012000948A1 (es) 2012-12-14
US20120263766A1 (en) 2012-10-18
EP2488157A1 (en) 2012-08-22

Similar Documents

Publication Publication Date Title
ZA201106050B (en) Dye-polymers formulations
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
PL2464939T3 (pl) Udoskonalony nośnik przedmiotu obrabianego
GB0823269D0 (en) Formulations
IL269369A (en) The vehicles are improved
GB0919210D0 (en) Formulations
GB0914596D0 (en) Improved hatchcover
GB0821789D0 (en) Formulations
GB0907003D0 (en) Formulation
EP2307021A4 (en) FORMULATIONS
AP2013006687A0 (en) Formulations
GB201013513D0 (en) Formulations
GB201010667D0 (en) Formulations
IL217390A0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
AP2013006689A0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
GB0911213D0 (en) Formulation
GB0907410D0 (en) Formulation
GB0914489D0 (en) Improved formulations
GB0917744D0 (en) Formulations
GB0811447D0 (en) Formulations
GB0823486D0 (en) Formulations